Cargando…
Relevant issues in tumor regression grading of histopathological response to neoadjuvant treatment in adenocarcinomas of the esophagus and gastroesophageal junction
Multimodality treatment combining surgery and oncologic treatment has become widely applied in curative treatment of esophageal and gastroesophageal junction adenocarcinoma. There is a need for a standardized tumor regression grade scoring system for clinically relevant effects of neoadjuvant treatm...
Autores principales: | Klevebro, F, Tsekrekos, A, Low, D, Lundell, L, Vieth, M, Detlefsen, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273185/ https://www.ncbi.nlm.nih.gov/pubmed/32141500 http://dx.doi.org/10.1093/dote/doaa005 |
Ejemplares similares
-
Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction
por: Kamarajah, S. K., et al.
Publicado: (2020) -
Association between time interval from neoadjuvant chemoradiotherapy to surgery and complete histological tumor response in esophageal and gastroesophageal junction cancer: a national cohort study
por: Klevebro, F, et al.
Publicado: (2019) -
History of esophagectomy for cancer of the esophagus and the gastroesophageal junction
por: Lerut, Toni, et al.
Publicado: (2021) -
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials
por: Zhao, Xin, et al.
Publicado: (2018) -
Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction
por: Nusrath, Syed, et al.
Publicado: (2022)